Steinmetz J, Spyckerelle Y, Fournier B, Boulangé M, Leclère J, Giordanella J P
Centre technique d'appui et de formation des Centres d'examens de santé, 2, avenue du Doyen-J.-Parisot, 54500 Vandoeuvre-lès-Nancy.
Ann Endocrinol (Paris). 2000 Dec;61(6):501-507.
Thyroid stimulating hormone (TSH) was measured in a sample of 4,403 women, aged 45-70 years in 11 Centers for health screening, to define the interest of this biological indicator for screening subclinical hypothyroidism. The aim of this work was to describe clinical signs, symptoms and medical history linked to TSH variations, to estimate the distribution of this hormone in a general population and reference limits in a selected subgroup. All the participating laboratories used the same third-generation immunoassay on fresh samples. In the general sample population (age mean: 55.2 6.9 yrs), 1.1% presented hyperthyroidism (TSH<0.3 mU/l) and 0.4% had hypothyroidism (TSH>12 mU/l). In the sub-sample of 151 women (3.4%) with TSH between 4-12 mU/l, 131 had subclinical hypothyroidism (FT4>8 ng/l). The TSH mean was significantly lower (- 10 to - 23%) in women presenting a nodular goiter. Inversely, TSH was higher in women with muscle cramps, asthenia, recent weight gain, morning eyelid edema and abnormal electrocardiogram. The reference limits for percentiles 2.5 and 97.5 were 0.43 and 3.71 mU/l on 1 348 subjects after excluding women having one of these symptoms or taking any drug treatment.
在11个健康筛查中心,对4403名年龄在45至70岁之间的女性样本进行了促甲状腺激素(TSH)检测,以确定该生物学指标在筛查亚临床甲状腺功能减退方面的价值。这项工作的目的是描述与TSH变化相关的临床体征、症状和病史,估计该激素在一般人群中的分布情况以及选定亚组的参考值范围。所有参与实验室均对新鲜样本使用相同的第三代免疫测定法。在总体样本人群(平均年龄:55.2±6.9岁)中,1.1%的人患有甲状腺功能亢进(TSH<0.3 mU/l),0.4%的人患有甲状腺功能减退(TSH>12 mU/l)。在TSH值介于4至12 mU/l之间的151名女性亚样本(3.4%)中,131人患有亚临床甲状腺功能减退(FT4>8 ng/l)。患有结节性甲状腺肿的女性TSH平均值显著较低(降低10%至23%)。相反,有肌肉痉挛、乏力、近期体重增加、晨起眼睑水肿和心电图异常的女性TSH值较高。在排除有上述任何一种症状或正在接受任何药物治疗的女性后,对1348名受试者进行检测,第2.5百分位数和第97.5百分位数的参考值分别为0.43和3.71 mU/l。